How to Optimally Deliver Vaginal Cuff Brachytherapy for Endometrial Cancer in Your Practice: Tips and Tricks From the Experts
Vaginal cuff brachytherapy (VBT) is a critical part of a radiation oncologist's practice and is routinely offered both at academic sites and within the community. However, in the modern era, many are stretched increasingly thin and have fewer resources to work with.
Category
  • Brachytherapy
  • Gynecologic
Format
  • onDemand
  • Sessions onDemand
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Certificate of Attendance
Cost $299.00
The Evolution of Cancer Within a Patient: Tumor Phylogenetics and Implications for Local Therapy
Tumor phylogenetics (or cancer phylogenetics) is the scientific method used to consider cancer biology through the lens of computational evolutionary biology.
Category
  • Oligometastatic
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Brain Metastases Radiotherapy While Mitigating Radionecrosis and Neurotoxicity in a Community Setting
There are many strategies for managing brain mets with radiotherapy.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Gynecologic Tumor Board–Case-Based Discussion of the Molecular & Treatment Approach Updates for the Management of Endometrial, Vulvar & Cervical Cancers
There have been many recent studies that further differentiate gynecologic cancers and their management relating to pathologic features, such as molecular status.
Category
  • Gynecologic
  • Immunotherapy
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Salvage Therapy for Local-Regional Breast Cancer Recurrence: What, When, and How Much?
Breast cancer recurrence after prior definitive multimodality treatment is an increasingly common clinical situation faced by practitioners, with long-term new primary or recurrent non-metastatic locoregional recurrence developing not infrequently over 10 years following initial treatment.
Category
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
The Hidden Risks of Artificial Intelligence (AI): Biases and Disparities in the Global Development and Deployment of AI for Cancer Care
Artificial intelligence (AI) and machine learning (ML) are beginning to have a dramatic impact on the field of medicine in the domains of clinical decision making, radiation planning and interactions between patients and their medical teams.
Category
  • Health Policy/Informatics
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Science Highlights 2024: Gastrointestinal Cancer
This session highlights the most clinically relevant abstracts within the Gastrointestinal Cancer track of the 2024 ASTRO Annual Meeting scientific program.
Category
  • Gastrointestinal
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $0.00
Science Highlights 2024: Head and Neck Cancer
This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2024 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $79.00
ASTRO/SIO Joint Session-Update: Integrative Oncology in Cancer Care
Significant data reveal that cancer patients use complementary/integrative therapies and may not share this with their physician team.
Category
  • General RO
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
“Let’s Talk About It!” - Biology and Management of Sexual Toxicity Resulting from Prostate Cancer Radiotherapy
Radiation therapy-induced erectile dysfunction (RI-ED) occurs in over 50% of men treated for prostate cancer. The etiologies are likely multifactorial, consisting of a neurological, vascular and endocrine component.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages